A multicenter, phase III study of carboplatin/paclitaxel versus oral uracil-tegafur as the adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): Planned interim analyses.
暂无分享,去创建一个
S. Toyooka | M. Aoe | J. Sakamoto | M. Nakata | M. Yamashita | K. Hotta | H. Date | N. Watanabe | H. Tada | H. Nakamura